BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29734820)

  • 1. Family History of Alzheimer's Disease and Subjective Memory Performance.
    Haussmann R; Ganske S; Gruschwitz A; Werner A; Osterrath A; Lange J; Buthut M; Donix KL; Linn J; Donix M
    Am J Alzheimers Dis Other Demen; 2018 Nov; 33(7):458-462. PubMed ID: 29734820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family History of Alzheimer's Disease and Cortical Thickness in Patients With Dementia.
    Ganske S; Haussmann R; Gruschwitz A; Werner A; Osterrath A; Baumgaertel J; Lange J; Donix KL; Linn J; Donix M
    Am J Alzheimers Dis Other Demen; 2016 Aug; 31(5):450-6. PubMed ID: 27303063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semantic memory activation in amnestic mild cognitive impairment.
    Woodard JL; Seidenberg M; Nielson KA; Antuono P; Guidotti L; Durgerian S; Zhang Q; Lancaster M; Hantke N; Butts A; Rao SM
    Brain; 2009 Aug; 132(Pt 8):2068-78. PubMed ID: 19515831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies.
    Mak E; Gabel S; Su L; Williams GB; Arnold R; Passamonti L; Vazquez Rodríguez P; Surendranathan A; Bevan-Jones WR; Rowe JB; O'Brien JT
    Int Psychogeriatr; 2017 Apr; 29(4):545-555. PubMed ID: 28088928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
    Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
    Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Kontaxopoulou D; Beratis IN; Fragkiadaki S; Pavlou D; Andronas N; Yannis G; Economou A; Papanicolaou AC; Papageorgiou SG
    J Alzheimers Dis; 2018; 65(2):617-627. PubMed ID: 30056423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal Volume and Episodic Associative Memory Identify Memory Risk in Subjective Cognitive Decline Individuals in the CIMA-Q Cohort, Regardless of Cognitive Reserve Level and APOE4 Status.
    Caillaud M; Maltezos S; Hudon C; Mellah S; ; Belleville S
    J Alzheimers Dis; 2023; 94(3):1047-1056. PubMed ID: 37355896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
    Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
    Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionating the Rey Auditory Verbal Learning Test: Distinct roles of large-scale cortical networks in prodromal Alzheimer's disease.
    Putcha D; Brickhouse M; Wolk DA; Dickerson BC;
    Neuropsychologia; 2019 Jun; 129():83-92. PubMed ID: 30930301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of subjective cognitive deficits in patients with mild cognitive impairment.
    Loessner L; Matthes C; Haussmann R; Brandt MD; Sauer C; Espin M; Noppes F; Werner A; Linn J; Hummel T; Haehner A; Donix M
    Psychogeriatrics; 2022 Mar; 22(2):210-217. PubMed ID: 34939254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.
    Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D
    Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.
    Putcha D; Brickhouse M; O'Keefe K; Sullivan C; Rentz D; Marshall G; Dickerson B; Sperling R
    J Neurosci; 2011 Nov; 31(48):17680-8. PubMed ID: 22131428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
    Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
    Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.